Home / Stories
Stories & explainers
The SignalAn FDA panel backed the first multi-cancer blood test. Here's what the data actually show.Advisers voted 7–2 that Galleri's benefits outweigh its risks. The FDA's own briefing shows a test that is very specific, finds about a third of cancers within a year, and raises questions nobody has answered yet.Pop Health CheckWhen health media meets the evidence: what Dr. Oz, Goop and Belle Gibson teach about health claimsA TV show, a lifestyle brand and an influencer each sold health to millions. Researchers, a Senate panel, prosecutors and a court then checked the claims. Here is what they found, and the questions it leaves you to ask.Future Health ExplainedCleared, approved, De Novo, Breakthrough: how FDA medical device pathways workWhat "FDA-cleared", "FDA-approved", De Novo, IDE and Breakthrough designation actually mean, with examples from Texas medtech companies.Future Health ExplainedWhat is a liquid biopsy?A liquid biopsy looks for cancer cells or tumor DNA in blood. How it's used to guide treatment and monitor cancer, what blood-based screening can and can't do yet, and where Texas companies fit.